$3.09
-2.8%Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Last Annual Value
-21.40M
3-Year CAGR
4%
5-Year CAGR
-10%
10-Year CAGR
-17%
| Company | Net Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Sensus Healthcare, Inc. NASDAQ:SRTS | -21.40M | N/A | N/A | N/A | |
![]() Biodesix, Inc. NASDAQ:BDSX | 53.87M | 16.1% | N/A | N/A | |
![]() Pulmonx Corporation NASDAQ:LUNG | -13.64M | N/A | N/A | N/A | |
![]() Nephros, Inc. NASDAQ:NEPH | -2.35M | N/A | N/A | N/A | |
![]() vTv Therapeutics Inc. NASDAQ:VTVT | -88.93M | N/A | N/A | N/A | |
![]() Senti Biosciences, Inc. NASDAQ:SNTI | -14.64M | N/A | N/A | N/A | |
![]() PetMed Express, Inc. NASDAQ:PETS | -53.72M | N/A | N/A | N/A | |
![]() Cytosorbents Corporation NASDAQ:CTSO | 23.61M | 78.1% | N/A | N/A | |
![]() Spectral AI, Inc. NASDAQ:MDAI | -5.30M | N/A | N/A | N/A | |
![]() Karyopharm Therapeutics Inc. NASDAQ:KPTI | 173.07M | 11.5% | N/A | N/A | |
![]() Century Therapeutics, Inc. NASDAQ:IPSC | -18.29M | N/A | N/A | N/A |
Continue your SRTS research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.